Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_assertion type Assertion NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_head.
- NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_assertion description "[Furthermore, although some oncogenic (Kras, Pten/PI3K and Trp53) pathways that are frequently mutated, deleted or amplified in ovarian cancer are known, how these pathways initiate and drive specific morphological phenotypes and tumor outcomes remain unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_provenance.
- NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_assertion evidence source_evidence_literature NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_provenance.
- NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_assertion SIO_000772 21423204 NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_provenance.
- NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_assertion wasDerivedFrom befree-20140225 NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_provenance.
- NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_assertion wasGeneratedBy ECO_0000203 NP780409.RAStscnqjsNjD_oXQgq7GzGhkyemiU_H6wcpUB6nIiYog130_provenance.